0005 18 The share price of Tetracyclic Biology is in 3 yuan, why not go up?

Because the company behind this stock is not favored by investors, the current share price is still around three yuan, and the performance of this company is also problematic, so it is unlikely to rise in the future.

In fact, when many investors invest in stocks, they will do a lot of research on the company. Some stocks rose in a short time because everyone recognized a stock. There is something wrong with the stock of this company, so investors will not buy the stock of this company.

The performance of this company is relatively poor. By observing the financial statements of this company, we can find that the financial situation of this company is relatively poor, and the monthly sales revenue is also relatively poor. Because of this, many investors are not optimistic about this company, so the price will remain at around three yuan.

The negative sentiment of investors is not conducive to the rise of the company's stock. Many investors in the market are relatively negative, which has nothing to do with the future development of this company, so the price increase of this company's stock is also relatively weak. At present, the price remains at around three yuan, and I think the future price may exceed two yuan.

Many investors will choose better assets. Many investors have great choices in the market, because they can choose from about 4,000 stocks in the A-share market, and more companies can make more profits by buying these higher-quality stocks.

China's A-share market has become more and more perfect, and many investors have become more and more qualified. Investors will definitely do more research on a stock before making a decision. This is good for the whole market and investors, and it is also beneficial to the development of China's capital market.